1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. CARA THERAPEUTICS INC

Cara Therapeutics Inc

XNAS: CARA

Download real time

5.23 0.03 (0.58%)

54.60% Fall from 52W High

5,448 XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
15S
6W
1O
2T
23.9

Market Cap

Low in industry
-0.3

PE TTM

Negative PE TTM
0

PEG TTM

33.8

Price to Book

High in industry
0.0

Beta 1Year

Very Low volatility


Insider Trading disclosures for Cara Therapeutics Inc

The latest disclosure was made by Scott M. Terrillion in Cara Therapeutics Inc where a trade of 163 Common Stock done at an average price of $4.8 was reported to US exchanges on Feb. 28, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Scott M. Terrillion SECY; CHIEF COMPLIANCE & G.C. Sale of securities on an exchange or to another person at price $ 4.76 per share. 28 Feb 2025 163 7,190 (0%) 0% 4.8 776 Common Stock
Christopher A. Posner Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 4.75 per share. 28 Feb 2025 583 13,109 (0%) 0% 4.7 2,769 Common Stock
Christopher A. Posner Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 4.72 per share. 04 Feb 2025 372 13,692 (0%) 0% 4.7 1,756 Common Stock
Christopher A. Posner Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 0.29 per share. 04 Nov 2024 3,668 168,768 (0%) 0% 0.3 1,064 Common Stock
Christopher A. Posner Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 0.35 per share. 01 Aug 2024 4,149 172,436 (0%) 0% 0.3 1,452 Common Stock
Martin A. Vogelbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 301,295 411,007 (0%) 0% 0 Common Stock
Martin A. Vogelbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 390,000 390,000 - - Stock Option (Right to Buy)
Jeffrey L. Ives Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 150,647 198,485 (0%) 0% 0 Common Stock
Jeffrey L. Ives Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 195,000 195,000 - - Stock Option (Right to Buy)
Helen M. Boudreau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 195,000 195,000 - - Stock Option (Right to Buy)
Helen M. Boudreau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 150,647 150,647 (0%) 0% 0 Common Stock
Lisa von Moltke Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 195,000 195,000 - - Stock Option (Right to Buy)
Lisa von Moltke Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 150,647 183,009 (0%) 0% 0 Common Stock
Susan Shiff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 195,000 195,000 - - Stock Option (Right to Buy)
Susan Shiff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 150,647 202,085 (0%) 0% 0 Common Stock
Christopher A. Posner Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 0.75 per share. 02 May 2024 3,936 176,585 (0%) 0% 0.8 2,952 Common Stock
Scott M. Terrillion SECY; CHIEF COMPLIANCE & G.C. Sale of securities on an exchange or to another person at price $ 0.83 per share. 05 Apr 2024 2,753 88,247 (0%) 0% 0.8 2,285 Common Stock
Joana Goncalves CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 0.83 per share. 05 Apr 2024 2,753 53,365 (0%) 0% 0.8 2,285 Common Stock
Scott M. Terrillion SECY; CHIEF COMPLIANCE & G.C. Sale of securities on an exchange or to another person at price $ 0.89 per share. 29 Feb 2024 3,293 91,000 (0%) 0% 0.9 2,931 Common Stock
Christopher A. Posner Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 0.89 per share. 29 Feb 2024 5,834 180,521 (0%) 0% 0.9 5,192 Common Stock
Joana Goncalves CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 0.89 per share. 29 Feb 2024 3,293 56,118 (0%) 0% 0.9 2,931 Common Stock
Christopher A. Posner Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 0.53 per share. 08 Feb 2024 35,575 186,355 (0%) 0% 0.5 18,855 Common Stock
Terrillion Scott M. SECY; CHIEF COMPLIANCE & G.C. Sale of securities on an exchange or to another person at price $ 0.53 per share. 08 Feb 2024 7,770 94,293 (0%) 0% 0.5 4,118 Common Stock
D. Ryan Maynard CHIEF FINANCIAL OFFICER Sale of securities on an exchange or to another person at price $ 0.53 per share. 08 Feb 2024 5,488 8,012 (0%) 0% 0.5 2,909 Common Stock
Goncalves Joana CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 0.53 per share. 08 Feb 2024 7,770 59,411 (0%) 0% 0.5 4,118 Common Stock
Frederique Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 13,500 167,247 (0%) 0% 0 Common Stock
A. Posner Christopher Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 62,500 226,911 (0%) 0% 0 Common Stock
A. Posner Christopher Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 0.55 per share. 01 Feb 2024 4,981 221,930 (0%) 0% 0.6 2,740 Common Stock
Scott Terrillion M. SECY; CHIEF COMPLIANCE & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 13,500 102,063 (0%) 0% 0 Common Stock
Ryan Maynard D. CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 13,500 13,500 (0%) 0% 0 Common Stock
Joana Goncalves CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 13,500 67,181 (0%) 0% 0 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 3.51 per share. 23 Jun 2023 2,993 153,747 (0%) 0% 3.5 10,505 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 3.51 per share. 23 Jun 2023 2,483 88,563 (0%) 0% 3.5 8,715 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.51 per share. 23 Jun 2023 2,723 53,681 (0%) 0% 3.5 9,558 Common Stock
Harrison M. Bains Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 32,362 57,438 (0%) 0% 0 Common Stock
Harrison M. Bains Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 44,961 44,961 - - Stock Option (Right to Buy)
Martin A. Vogelbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 89,923 89,923 - - Stock Option (Right to Buy)
Martin A. Vogelbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 64,724 109,712 (0%) 0% 0 Common Stock
Jeffrey L. Ives Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 32,362 47,838 (0%) 0% 0 Common Stock
Jeffrey L. Ives Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 44,961 44,961 - - Stock Option (Right to Buy)
Lisa von Moltke Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 32,362 32,362 (0%) 0% 0 Common Stock
Lisa von Moltke Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 44,961 44,961 - - Stock Option (Right to Buy)
Susan Shiff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 44,961 44,961 - - Stock Option (Right to Buy)
Susan Shiff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 32,362 51,438 (0%) 0% 0 Common Stock
Christopher A. Posner Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.40 per share. 05 May 2023 3,869 172,514 (0%) 0% 4.4 17,024 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 4.91 per share. 04 Apr 2023 2,733 156,740 (0%) 0% 4.9 13,419 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 4.91 per share. 04 Apr 2023 2,481 91,046 (0%) 0% 4.9 12,182 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.91 per share. 04 Apr 2023 2,481 56,404 (0%) 0% 4.9 12,182 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 9.71 per share. 03 Mar 2023 6,802 159,473 (0%) 0% 9.7 66,047 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 9.71 per share. 03 Mar 2023 6,256 93,527 (0%) 0% 9.7 60,746 Common Stock
Christopher A. Posner Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.71 per share. 03 Mar 2023 5,987 176,383 (0%) 0% 9.7 58,134 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 9.71 per share. 03 Mar 2023 6,221 58,885 (0%) 0% 9.7 60,406 Common Stock
Ryan D. Maynard Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 81,000 81,000 - - Stock Option (Right to Buy)
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 81,000 81,000 - - Stock Option (Right to Buy)
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 81,000 81,000 - - Stock Option (Right to Buy)
Christopher A. Posner Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 250,000 250,000 - - Stock Option (Right to Buy)
Joana Goncalves Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 81,000 81,000 - - Stock Option (Right to Buy)
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 10.20 per share. 16 Feb 2023 2,265 65,106 (0%) 0% 10.2 23,103 Common Stock
Christopher A. Posner Director, President and CEO Sale of securities on an exchange or to another person at price $ 11.80 per share. 02 Feb 2023 4,191 182,370 (0%) 0% 11.8 49,454 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 10.81 per share. 17 Jan 2023 2,265 67,371 (0%) 0% 10.8 24,485 Common Stock
Lisa von Moltke Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 45,841 45,841 - - Stock Option (Right to Buy)
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 10.18 per share. 29 Dec 2022 2,265 69,636 (0%) 0% 10.2 23,058 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 11.27 per share. 21 Dec 2022 3,506 166,275 (0%) 0% 11.3 39,513 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 11.27 per share. 21 Dec 2022 2,561 99,783 (0%) 0% 11.3 28,862 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 11.27 per share. 21 Dec 2022 2,992 71,901 (0%) 0% 11.3 33,720 Common Stock
Christopher A. Posner Director, President and CEO Sale of securities on an exchange or to another person at price $ 11.13 per share. 16 Nov 2022 14,470 186,561 (0%) 0% 11.1 161,051 Common Stock
Martin A. Vogelbaum Director Sale of securities on an exchange or to another person at price $ 10.28 per share. 14 Sep 2022 10,800 44,988 (0%) 0% 10.3 111,024 Common Stock
Ryan D. Maynard Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2022 225,000 225,000 - - Stock Option (Right to Buy)
Harrison M. Bains Director Sale of securities on an exchange or to another person at price $ 9.05 per share. 15 Jul 2022 7,200 25,076 (0%) 0% 9.1 65,160 Common Stock
Jeffrey L. Ives Director Sale of securities on an exchange or to another person at price $ 9.05 per share. 15 Jul 2022 3,600 15,476 (0%) 0% 9.1 32,580 Common Stock
Richard Makara VP, Head of Accting;Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 7,500 13,583 (0%) 0% 0 Common Stock
Harrison M. Bains Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 11,876 32,276 (0%) 0% 0 Common Stock
Harrison M. Bains Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 16,996 16,996 - - Stock Option (Right to Buy)
Martin A. Vogelbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 23,752 43,912 (0%) 0% 0 Common Stock
Martin A. Vogelbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 11,876 55,788 (0%) 0% 0 Common Stock
Martin A. Vogelbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 33,993 33,993 - - Stock Option (Right to Buy)
Jeffrey L. Ives Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 11,876 19,076 (0%) 0% 0 Common Stock
Jeffrey L. Ives Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 16,996 16,996 - - Stock Option (Right to Buy)
Susan Shiff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 16,996 16,996 - - Stock Option (Right to Buy)
Susan Shiff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 11,876 19,076 (0%) 0% 0 Common Stock
Christopher A. Posner Director, President and CEO Sale of securities on an exchange or to another person at price $ 12.67 per share. 04 Apr 2022 2,006 201,031 (0%) 0% 12.7 25,416 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 11.91 per share. 01 Apr 2022 1,784 169,781 (0%) 0% 11.9 21,247 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 11.91 per share. 01 Apr 2022 1,642 102,344 (0%) 0% 11.9 19,556 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 11.91 per share. 01 Apr 2022 1,642 74,893 (0%) 0% 11.9 19,556 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 11.38 per share. 03 Mar 2022 1,787 103,986 (0%) 0% 11.4 20,336 Common Stock
Thomas Reilly Chief Financial Officer Sale of securities on an exchange or to another person at price $ 11.38 per share. 03 Mar 2022 2,044 37,811 (0%) 0% 11.4 23,261 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 10.29 per share. 25 Feb 2022 2,114 171,565 (0%) 0% 10.3 21,753 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 40,000 40,000 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 20,000 173,679 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 20,000 102,412 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 10.29 per share. 25 Feb 2022 1,972 100,440 (0%) 0% 10.3 20,292 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 40,000 40,000 - - Employee Stock Option (Right to Buy)
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 5,333 105,773 (0%) 0% 0 Common Stock
Christopher A. Posner Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 121,000 121,000 - - Stock Option (Right to Buy)
Christopher A. Posner Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 39,000 203,037 (0%) 0% 0 Common Stock
Joana Goncalves Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 20,000 78,507 (0%) 0% 0 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 10.29 per share. 25 Feb 2022 1,972 76,535 (0%) 0% 10.3 20,292 Common Stock
Joana Goncalves Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 80,000 80,000 - - Employee Stock Option (Right to Buy)
Thomas Reilly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 40,000 40,000 - - Employee Stock Option (Right to Buy)
Thomas Reilly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 10.29 per share. 25 Feb 2022 5,333 39,855 (0%) 0% 10.3 54,877 Common Stock
Thomas Reilly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 20,000 34,522 (0%) 0% 0 Common Stock
Jeffrey L. Ives Director Sale of securities on an exchange or to another person at price $ 16.04 per share. 12 Nov 2021 8,180 7,200 (0%) 0% 16.0 131,207 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 17.15 per share. 01 Nov 2021 1,000 45,900 (0%) 0% 17.2 17,150 Common Stock
Christopher Posner Director, Senior Advisor Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Oct 2021 566,000 566,000 - - Stock Option (Right to Buy)
Christopher Posner Director, Senior Advisor Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Oct 2021 142,000 164,037 (0%) 0% 0 Common Stock
Christopher Posner Director, Senior Advisor Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Oct 2021 5,941 22,037 (0%) 0% 0 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.00 per share. 27 Oct 2021 1,000 46,900 (0%) 0% 15 15,000 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 15.47 per share. 07 Sep 2021 20,000 991,405 (2%) 0% 15.5 309,400 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 14.20 per share. 30 Aug 2021 8,440 1,011,405 (2%) 0% 14.2 119,848 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 14.20 per share. 30 Aug 2021 3,847 141,072 (0%) 0% 14.2 54,627 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 14.20 per share. 30 Aug 2021 1,759 70,917 (0%) 0% 14.2 24,978 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 14.20 per share. 30 Aug 2021 2,110 47,900 (0%) 0% 14.2 29,962 Common Stock
Thomas Reilly Chief Financial Officer Sale of securities on an exchange or to another person at price $ 14.20 per share. 30 Aug 2021 1,982 3,352 (0%) 0% 14.2 28,144 Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2021 17,334 1,019,845 (2%) 0% 0 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2021 9,600 144,919 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2021 5,334 72,676 (0%) 0% 0 Common Stock
Joana Goncalves Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2021 6,400 50,010 (0%) 0% 0 Common Stock
Thomas Reilly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2021 5,334 5,334 (0%) 0% 0 Common Stock
Harrison M. Bains Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 10,800 10,800 - - Stock Option (Right to Buy)
Harrison M. Bains Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 7,200 20,400 (0%) 0% 0 Common Stock
Martin A. Vogelbaum Director Sale of securities on an exchange or to another person at price $ 13.05 per share. 03 Jun 2021 8,640 20,160 (0%) 0% 13.1 112,752 Common Stock
Martin A. Vogelbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 14,400 28,800 (0%) 0% 0 Common Stock
Martin A. Vogelbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 21,600 21,600 - - Stock Option (Right to Buy)
Jeffrey L. Ives Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 10,800 10,800 - - Stock Option (Right to Buy)
Jeffrey L. Ives Director Sale of securities on an exchange or to another person at price $ 13.05 per share. 03 Jun 2021 2,520 15,380 (0%) 0% 13.1 32,886 Common Stock
Jeffrey L. Ives Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 7,200 17,900 (0%) 0% 0 Common Stock
Christopher Posner Director Sale of securities on an exchange or to another person at price $ 13.04 per share. 03 Jun 2021 2,304 16,096 (0%) 0% 13.0 30,044 Common Stock
Christopher Posner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 7,200 18,400 (0%) 0% 0 Common Stock
Christopher Posner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 10,800 10,800 - - Stock Option (Right to Buy)
Susan Shiff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 7,200 7,200 (0%) 0% 0 Common Stock
Susan Shiff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2021 10,800 10,800 - - Stock Option (Right to Buy)
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 27.63 per share. 21 Apr 2021 3,000 43,610 (0%) 0% 27.6 82,890 Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 103,000 103,000 - - Employee Stock Option (Right to Buy)
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 52,000 1,002,511 (2%) 0% 0 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 16,000 135,319 (0%) 0% 0 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 32,000 32,000 - - Employee Stock Option (Right to Buy)
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 16,000 67,342 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 32,000 32,000 - - Employee Stock Option (Right to Buy)
Joana Goncalves Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 32,000 32,000 - - Employee Stock Option (Right to Buy)
Joana Goncalves Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 16,000 46,610 (0%) 0% 0 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 19.65 per share. 22 Mar 2021 3,000 30,610 (0%) 0% 19.7 58,950 Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 10,000 953,614 (2%) 0% 0 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 17.98 per share. 04 Mar 2021 3,103 950,511 (2%) 0% 18.0 55,792 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 10,000 122,677 (0%) 0% 0 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 17.98 per share. 04 Mar 2021 3,358 119,319 (0%) 0% 18.0 60,377 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 10,000 54,432 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 17.98 per share. 04 Mar 2021 3,090 51,342 (0%) 0% 18.0 55,558 Common Stock
Joana Goncalves Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 10,000 36,703 (0%) 0% 0 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 17.98 per share. 04 Mar 2021 3,093 33,610 (0%) 0% 18.0 55,612 Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2021 18,750 955,343 (2%) 0% 0 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 19.33 per share. 23 Feb 2021 11,729 943,614 (2%) 0% 19.3 226,722 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 19.33 per share. 23 Feb 2021 5,003 112,677 (0%) 0% 19.3 96,708 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2021 8,000 117,680 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2021 6,000 48,436 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 19.33 per share. 23 Feb 2021 4,004 44,432 (0%) 0% 19.3 77,397 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 19.33 per share. 23 Feb 2021 3,372 26,703 (0%) 0% 19.3 65,181 Common Stock
Joana Goncalves Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2021 4,000 30,075 (0%) 0% 0 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 19.73 per share. 22 Feb 2021 2,000 26,075 (0%) 0% 19.7 39,460 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 20.12 per share. 21 Jan 2021 2,000 28,075 (0%) 0% 20.1 40,240 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 15.30 per share. 30 Dec 2020 6,078 936,593 (2%) 0% 15.3 92,993 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 15.30 per share. 30 Dec 2020 2,812 109,680 (0%) 0% 15.3 43,024 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 15.30 per share. 30 Dec 2020 1,946 42,436 (0%) 0% 15.3 29,774 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.30 per share. 30 Dec 2020 1,298 30,075 (0%) 0% 15.3 19,859 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 16.00 per share. 23 Dec 2020 5,000 942,671 (2%) 0% 16 80,000 Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 18,750 947,671 (2%) 0% 0 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 8,000 112,492 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 6,000 44,382 (0%) 0% 0 Common Stock
Joana Goncalves Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 4,000 31,373 (0%) 0% 0 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.00 per share. 21 Dec 2020 2,000 27,373 (0%) 0% 15 30,000 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 14.95 per share. 16 Dec 2020 5,000 928,921 (1%) 0% 15.0 74,750 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 15.29 per share. 10 Dec 2020 7,500 933,921 (1%) 0% 15.3 114,675 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.31 per share. 23 Nov 2020 2,000 29,373 (0%) 0% 15.3 30,620 Common Stock
Jeffrey L. Ives Director Sale of securities on an exchange or to another person at price $ 15.75 per share. 19 Nov 2020 2,500 10,700 (0%) 0% 15.7 39,373 Common Stock
Christopher Posner Director Sale of securities on an exchange or to another person at price $ 15.82 per share. 19 Nov 2020 2,000 11,200 (0%) 0% 15.8 31,638 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 16.00 per share. 17 Nov 2020 11,799 941,421 (2%) 0% 16 188,784 Common Stock
Martin A. Vogelbaum Director Sale of securities on an exchange or to another person at price $ 16.09 per share. 17 Nov 2020 6,000 14,400 (0%) 0% 16.1 96,540 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.00 per share. 10 Nov 2020 2,000 31,373 (0%) 0% 15 30,000 Common Stock
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.00 per share. 20 Oct 2020 2,000 33,373 (0%) 0% 15 30,000 Common Stock
Thomas Reilly Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 175,000 175,000 - - Stock Option (Right to Buy)
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 16.00 per share. 03 Sep 2020 3,201 953,220 (2%) 0% 16 51,216 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 16.42 per share. 03 Aug 2020 5,000 956,421 (2%) 0% 16.4 82,100 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 17.11 per share. 01 Jul 2020 5,000 961,421 (2%) 0% 17.1 85,550 Common Stock
Susan Shiff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2020 38,000 38,000 - - Stock Option (Right to Buy)
Joana Goncalves Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.20 per share. 10 Jun 2020 10,627 35,373 (0%) 0% 15.2 161,530 Common Stock
Joana Goncalves Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2020 30,000 46,000 (0%) 0% 0 Common Stock
Harrison M. Bains Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 7,200 13,200 (0%) 0% 0 Common Stock
Harrison M. Bains Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 10,800 10,800 - - Stock Option (Right to Buy)
Martin A. Vogelbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 21,600 21,600 - - Stock Option (Right to Buy)
Martin A. Vogelbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 14,400 20,400 (0%) 0% 0 Common Stock
Jeffrey L. Ives Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 7,200 13,200 (0%) 0% 0 Common Stock
Jeffrey L. Ives Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 10,800 10,800 - - Stock Option (Right to Buy)
Christopher Posner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 10,800 10,800 - - Stock Option (Right to Buy)
Christopher Posner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2020 7,200 13,200 (0%) 0% 0 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 16.00 per share. 01 Jun 2020 700 970,721 (2%) 0% 16 11,200 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 16.01 per share. 01 Jun 2020 4,300 966,421 (2%) 0% 16.0 68,843 Common Stock
Jeffrey L. Ives Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2020 1,000 0 - - Stock Option (Right to Buy)
Jeffrey L. Ives Director Sale of securities on an exchange or to another person at price $ 16.00 per share. 01 Jun 2020 1,000 6,000 (0%) 0% 16 16,000 Common Stock
Jeffrey L. Ives Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.94 per share. 01 Jun 2020 1,000 7,000 (0%) 0% 9.9 9,940 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 16.00 per share. 20 May 2020 1,200 975,292 (2%) 0% 16 19,200 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 16.00 per share. 20 May 2020 371 971,421 (2%) 0% 16 5,936 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 16.00 per share. 20 May 2020 3,500 971,792 (2%) 0% 16 56,000 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 16.00 per share. 12 May 2020 4,929 976,492 (2%) 0% 16 78,864 Common Stock
Jeffrey L. Ives Director Sale of securities on an exchange or to another person at price $ 16.00 per share. 12 May 2020 2,500 6,000 (0%) 0% 16 40,000 Common Stock
Jeffrey L. Ives Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 May 2020 2,500 1,000 - - Stock Option (Right to Buy)
Jeffrey L. Ives Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.94 per share. 12 May 2020 2,500 8,500 (0%) 0% 9.9 24,850 Common Stock
Jeffrey L. Ives Director Sale of securities on an exchange or to another person at price $ 16.00 per share. 21 Apr 2020 2,500 6,000 (0%) 0% 16 40,000 Common Stock
Jeffrey L. Ives Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Apr 2020 2,500 3,500 - - Stock Option (Right to Buy)
Jeffrey L. Ives Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.94 per share. 21 Apr 2020 2,500 8,500 (0%) 0% 9.9 24,850 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 15.56 per share. 17 Apr 2020 6,348 981,421 (2%) 0% 15.6 98,775 Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2020 20,000 987,769 (2%) 0% 0 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2020 37,500 117,386 (0%) 0% 0 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 15.58 per share. 17 Apr 2020 12,894 104,492 (0%) 0% 15.6 200,889 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 15.56 per share. 17 Apr 2020 2,721 38,382 (0%) 0% 15.6 42,339 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2020 8,334 41,103 (0%) 0% 0 Common Stock
Jeffrey L. Ives Director Sale of securities on an exchange or to another person at price $ 16.00 per share. 04 Mar 2020 2,500 6,000 (0%) 0% 16 40,000 Common Stock
Jeffrey L. Ives Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2020 2,500 6,000 - - Stock Option (Right to Buy)
Jeffrey L. Ives Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.94 per share. 04 Mar 2020 2,500 8,500 (0%) 0% 9.9 24,850 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 16.05 per share. 02 Jan 2020 10,000 917,769 (1%) 0% 16.1 160,500 Common Stock
Jeffrey L. Ives Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2020 2,500 11,000 - - Stock Option (Right to Buy)
Jeffrey L. Ives Director Sale of securities on an exchange or to another person at price $ 16.13 per share. 02 Jan 2020 2,500 6,000 (0%) 0% 16.1 40,325 Common Stock
Jeffrey L. Ives Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.94 per share. 02 Jan 2020 2,500 8,500 (0%) 0% 9.9 24,850 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 25.79 per share. 02 Dec 2019 10,000 918,468 (1%) 0% 25.8 257,900 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 17.05 per share. 02 Dec 2019 10,699 927,769 (1%) 0% 17.1 182,418 Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2019 20,000 938,468 (2%) 0% 0 Common Stock
Jeffrey L. Ives None Sale of securities on an exchange or to another person at price $ 25.83 per share. 02 Dec 2019 2,500 6,000 (0%) 0% 25.8 64,575 Common Stock
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Dec 2019 2,500 0 - - Stock Option (Right to Buy)
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.32 per share. 02 Dec 2019 2,500 8,500 (0%) 0% 5.3 13,300 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Sale of securities on an exchange or to another person at price $ 17.05 per share. 02 Dec 2019 4,755 17,441 (0%) 0% 17.1 81,073 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2019 8,333 22,196 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2019 8,333 20,749 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 17.05 per share. 02 Dec 2019 3,980 16,769 (0%) 0% 17.1 67,859 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 20.79 per share. 01 Nov 2019 5,000 928,468 (1%) 0% 20.8 103,950 Common Stock
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2019 2,500 2,500 - - Stock Option (Right to Buy)
Jeffrey L. Ives None Sale of securities on an exchange or to another person at price $ 20.68 per share. 01 Nov 2019 2,500 6,000 (0%) 0% 20.7 51,700 Common Stock
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.32 per share. 01 Nov 2019 2,500 8,500 (0%) 0% 5.3 13,300 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 19.91 per share. 25 Oct 2019 4,000 63,886 (0%) 0% 19.9 79,640 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 19.33 per share. 18 Oct 2019 4,000 67,886 (0%) 0% 19.3 77,320 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 18.70 per share. 11 Oct 2019 4,000 71,886 (0%) 0% 18.7 74,800 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 19.19 per share. 04 Oct 2019 4,000 75,886 (0%) 0% 19.2 76,760 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 18.28 per share. 01 Oct 2019 10,000 933,468 (1%) 0% 18.3 182,800 Common Stock
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2019 2,500 5,000 - - Stock Option (Right to Buy)
Jeffrey L. Ives None Sale of securities on an exchange or to another person at price $ 18.21 per share. 01 Oct 2019 2,500 6,000 (0%) 0% 18.2 45,525 Common Stock
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.32 per share. 01 Oct 2019 2,500 8,500 (0%) 0% 5.3 13,300 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 23.26 per share. 03 Sep 2019 5,000 943,468 (2%) 0% 23.3 116,300 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 22.92 per share. 03 Sep 2019 20,000 79,886 (0%) 0% 22.9 458,400 Common Stock
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2019 2,500 7,500 - - Stock Option (Right to Buy)
Jeffrey L. Ives None Sale of securities on an exchange or to another person at price $ 23.31 per share. 03 Sep 2019 2,500 6,000 (0%) 0% 23.3 58,275 Common Stock
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.32 per share. 03 Sep 2019 2,500 8,500 (0%) 0% 5.3 13,300 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 23.27 per share. 01 Aug 2019 10,000 948,468 (2%) 0% 23.3 232,700 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 23.24 per share. 01 Aug 2019 20,000 99,886 (0%) 0% 23.2 464,800 Common Stock
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.32 per share. 01 Aug 2019 2,500 8,500 (0%) 0% 5.3 13,300 Common Stock
Jeffrey L. Ives None Sale of securities on an exchange or to another person at price $ 23.24 per share. 01 Aug 2019 2,500 6,000 (0%) 0% 23.2 58,100 Common Stock
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2019 2,500 10,000 - - Stock Option (Right to Buy)
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 27.50 per share. 17 Jul 2019 8,996 119,886 (0%) 0% 27.5 247,390 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.06 per share. 15 Jul 2019 37,431 51,294 (0%) 0% 14.1 526,280 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Sale of securities on an exchange or to another person at price $ 25.00 per share. 15 Jul 2019 37,431 13,863 (0%) 0% 25 935,775 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2019 37,431 299,444 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 21.90 per share. 01 Jul 2019 20,000 128,882 (0%) 0% 21.9 438,000 Common Stock
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2019 2,500 12,500 - - Stock Option (Right to Buy)
Jeffrey L. Ives None Sale of securities on an exchange or to another person at price $ 21.75 per share. 01 Jul 2019 2,500 6,000 (0%) 0% 21.8 54,375 Common Stock
Jeffrey L. Ives None Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.32 per share. 01 Jul 2019 2,500 8,500 (0%) 0% 5.3 13,300 Common Stock
Harrison M. Bains None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2019 9,000 9,000 - - Stock Option (Right to Buy)
Harrison M. Bains None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2019 6,000 6,000 (0%) 0% 0 Common Stock
Martin A. Vogelbaum None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2019 6,000 6,000 (0%) 0% 0 Common Stock
Jeffrey L. Ives None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2019 9,000 9,000 - - Stock Option (Right to Buy)
Jeffrey L. Ives None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2019 6,000 6,000 (0%) 0% 0 Common Stock
Christopher Posner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2019 9,000 9,000 - - Stock Option (Right to Buy)
Christopher Posner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2019 6,000 6,000 (0%) 0% 0 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 21.42 per share. 28 May 2019 5,528 958,468 (2%) 0% 21.4 118,410 Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2019 20,000 963,996 (2%) 0% 0 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2019 37,500 160,279 (0%) 0% 0 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 21.19 per share. 28 May 2019 11,397 148,882 (0%) 0% 21.2 241,502 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2019 8,333 16,359 (0%) 0% 0 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Sale of securities on an exchange or to another person at price $ 21.39 per share. 28 May 2019 2,496 13,863 (0%) 0% 21.4 53,389 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2019 8,333 14,719 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 21.38 per share. 28 May 2019 2,303 12,416 (0%) 0% 21.4 49,238 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2019 16,041 336,875 - - Employee Stock Option (Right to Buy)
Mani Mohindru CFO & Chief Strategy Officer Sale of securities on an exchange or to another person at price $ 19.12 per share. 13 Mar 2019 16,041 8,026 (0%) 0% 19.1 306,704 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.06 per share. 13 Mar 2019 16,041 24,067 (0%) 0% 14.1 225,536 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 18.87 per share. 12 Mar 2019 16,803 122,779 (0%) 0% 18.9 317,073 Common Stock
Frederique Menzaghi Chief Scientific Off,SVP-R&D Sale of securities on an exchange or to another person at price $ 17.50 per share. 12 Mar 2019 3,197 139,582 (0%) 0% 17.5 55,948 Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2019 235,000 235,000 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi Chief Scientific Off,SVP-R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2019 150,000 150,000 - - Employee Stock Option (Right to Buy)
Mani Mohindru CFO & Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2019 75,000 75,000 - - Employee Stock Option (Right to Buy)
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2019 75,000 75,000 - - Employee Stock Option (Right to Buy)
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 17.04 per share. 01 Mar 2019 9,792 943,996 (2%) 0% 17.0 166,856 Common Stock
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 17.50 per share. 28 Feb 2019 1,500 142,779 (0%) 0% 17.5 26,250 Common Stock
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 17.50 per share. 25 Feb 2019 2,200 144,279 (0%) 0% 17.5 38,500 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 14.99 per share. 01 Feb 2019 20,000 953,788 (2%) 0% 15.0 299,800 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 13.13 per share. 02 Jan 2019 15,000 978,788 (2%) 0% 13.1 196,950 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 15.04 per share. 02 Jan 2019 5,000 973,788 (2%) 0% 15.0 75,200 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 12.53 per share. 28 Dec 2018 15,825 993,788 (2%) 0% 12.5 198,287 Common Stock
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 12.53 per share. 28 Dec 2018 4,300 146,479 (0%) 0% 12.5 53,879 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Sale of securities on an exchange or to another person at price $ 12.55 per share. 28 Dec 2018 4,500 8,026 (0%) 0% 12.6 56,475 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Sale of securities on an exchange or to another person at price $ 12.51 per share. 28 Dec 2018 3,100 6,386 (0%) 0% 12.5 38,781 Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Dec 2018 38,221 1,009,613 (2%) 0% 0 Common Stock
Frederique Menzaghi Sr VP-Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Dec 2018 11,779 150,779 (0%) 0% 0 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Dec 2018 12,526 12,526 (0%) 0% 0 Common Stock
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Dec 2018 9,486 9,486 (0%) 0% 0 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 18.17 per share. 03 Dec 2018 20,000 971,392 (2%) 0% 18.2 363,400 Common Stock
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 18.36 per share. 03 Dec 2018 3,000 139,000 (0%) 0% 18.4 55,080 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Sale of securities on an exchange or to another person at price $ 18.50 per share. 15 Nov 2018 16,042 0 (0%) 0% 18.5 296,777 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.06 per share. 15 Nov 2018 16,042 16,042 (0%) 0% 14.1 225,551 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2018 16,042 352,916 - - Employee Stock Option (Right to Buy)
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 18.78 per share. 01 Nov 2018 20,000 991,392 (2%) 0% 18.8 375,600 Common Stock
Frederique Menzaghi Sr VP-Research & Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2018 40,000 0 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 18.77 per share. 01 Nov 2018 3,000 142,000 (0%) 0% 18.8 56,310 Common Stock
Frederique Menzaghi Sr VP-Research & Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.05 per share. 01 Nov 2018 40,000 145,000 (0%) 0% 2.1 82,000 Common Stock
Joana Goncalves Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2018 250,000 250,000 - - Employee Stock Option (Right to Buy)
Joseph Stauffer Chief Medical Officer Sale of securities on an exchange or to another person at price $ 20.69 per share. 17 Oct 2018 970 2,000 (0%) 0% 20.7 20,069 Common Stock
Joseph Stauffer Chief Medical Officer Sale of securities on an exchange or to another person at price $ 20.08 per share. 17 Oct 2018 10,472 2,970 (0%) 0% 20.1 210,278 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Sale of securities on an exchange or to another person at price $ 20.19 per share. 17 Oct 2018 16,042 0 (0%) 0% 20.2 323,888 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Oct 2018 16,042 368,958 - - Employee Stock Option (Right to Buy)
Mani Mohindru CFO & Chief Strategy Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.06 per share. 17 Oct 2018 16,042 16,042 (0%) 0% 14.1 225,551 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 23.79 per share. 01 Oct 2018 20,000 1,011,392 (2%) 0% 23.8 475,800 Common Stock
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 23.99 per share. 01 Oct 2018 3,000 95,000 (0%) 0% 24.0 71,970 Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 19.71 per share. 04 Sep 2018 20,000 1,031,392 (2%) 0% 19.7 394,200 Common Stock
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 19.81 per share. 04 Sep 2018 3,000 98,000 (0%) 0% 19.8 59,430 Common Stock
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 18.89 per share. 20 Aug 2018 3,000 101,000 (0%) 0% 18.9 56,670 Common Stock
Frederique Menzaghi Sr VP-Research & Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2018 10,000 0 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi Sr VP-Research & Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. 06 Aug 2018 10,000 114,000 (0%) 0% 2.3 22,500 Common Stock
Christopher Posner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2018 35,000 35,000 - - Stock Option (Right to Buy)
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 20.64 per share. 10 Jul 2018 20,000 1,051,392 (3%) 0% 20.6 412,800 Common Stock
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 19.00 per share. 02 Jul 2018 3,000 104,000 (0%) 0% 19 57,000 Common Stock
Harrison M. Bains None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2018 18,000 18,000 - - Stock Option (Right to Buy)
Martin A. Vogelbaum None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2018 18,000 18,000 - - Stock Option (Right to Buy)
Jeffrey L. Ives None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2018 18,000 18,000 - - Stock Option (Right to Buy)
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 15.49 per share. 01 Jun 2018 3,000 107,000 (0%) 0% 15.5 46,470 Common Stock
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 15.19 per share. 23 May 2018 9,000 110,000 (0%) 0% 15.2 136,710 Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 187,500 187,500 - - Employee Stock Option (Right to Buy)
Joseph Stauffer Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 57,750 57,750 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi Sr VP-Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 57,750 57,750 - - Employee Stock Option (Right to Buy)
Scott M. Terrillion Secy; Chief Compliance & G.C. Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 46,500 46,500 - - Employee Stock Option (Right to Buy)
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 15.00 per share. 16 Feb 2018 5,400 1,071,392 (3%) 0% 15 81,000 Common Stock
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 15.02 per share. 15 Feb 2018 3,000 119,000 (0%) 0% 15.0 45,060 Common Stock
Derek T. Chalmers Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.00 per share. 24 Jan 2018 3,000 1,076,792 (3%) 0% 6 18,000 Common Stock
Derek T. Chalmers Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jan 2018 3,000 191,000 - - Employee Stock Option (Right to Buy)
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 15.00 per share. 24 Jan 2018 12,500 1,073,792 (3%) 0% 15 187,500 Common Stock
Frederique Menzaghi Sr VP-Research & Development Sale of securities on an exchange or to another person at price $ 15.00 per share. 24 Jan 2018 15,000 122,000 (0%) 0% 15 225,000 Common Stock
Frederique Menzaghi Sr VP-Research & Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Nov 2017 20,000 0 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi Sr VP-Research & Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. 07 Nov 2017 20,000 137,000 (0%) 0% 2.5 49,600 Common Stock
Derek T. Chalmers Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2017 20,000 0 - - Employee Stock Option (Right to Buy)
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 12.66 per share. 01 Nov 2017 16,000 1,066,292 (3%) 0% 12.7 202,560 Common Stock
Derek T. Chalmers Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. 01 Nov 2017 20,000 1,086,292 (3%) 0% 2.5 49,600 Common Stock
Mani Mohindru CFO & Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2017 385,000 385,000 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 15.00 per share. 04 Aug 2017 3,000 117,000 (0%) 0% 15 45,000 Common Stock
Josef Schoell Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. 26 Jul 2017 4,000 50,000 (0%) 0% 2.3 9,000 Common Stock
Josef Schoell Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jul 2017 4,000 0 - - Employee Stock Option (Right to Buy)
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 15.05 per share. 14 Jul 2017 25,000 1,082,292 (3%) 0% 15.1 376,250 Common Stock
Derek T. Chalmers Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jul 2017 10,000 20,000 - - Employee Stock Option (Right to Buy)
Derek T. Chalmers Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. 14 Jul 2017 10,000 1,107,292 (3%) 0% 2.5 24,800 Common Stock
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 15.00 per share. 14 Jul 2017 3,000 120,000 (0%) 0% 15 45,000 Common Stock
Dean Slagel None Sale of securities on an exchange or to another person at price $ 25.81 per share. 29 Jun 2017 229,138 1,085,200 (3%) 0% 25.8 5,914,052 Common Stock
Dean Slagel None Sale of securities on an exchange or to another person at price $ 26.58 per share. 29 Jun 2017 20,862 1,064,338 (3%) 0% 26.6 554,512 Common Stock
Harrison M. Bains None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Martin A. Vogelbaum None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Dean Slagel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Jeffrey L. Ives None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 225,000 225,000 - - Employee Stock Option (Right to Buy)
Michael E. Lewis Chief Scientific Advisor Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 20,000 20,000 - - Employee Stock Option (Right to Buy)
Joseph Stauffer Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 75,000 75,000 - - Employee Stock Option (Right to Buy)
Josef Schoell Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 55,000 55,000 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi VP-Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 75,000 75,000 - - Employee Stock Option (Right to Buy)
Harrison M. Bains None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (Right to Buy)
Martin A. Vogelbaum None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (Right to Buy)
Dean Slagel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (Right to Buy)
Jeffrey L. Ives None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (Right to Buy)
Michael E. Lewis Chief Scientific Advisor Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2016 20,000 20,000 - - Stock Option (Right to Buy)
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Apr 2016 6,000 123,000 - - Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2016 194,000 194,000 - - Employee Stock Option (Right to Buy)
Joseph Stauffer Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2016 66,000 66,000 - - Employee Stock Option (Right to Buy)
Josef Schoell Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2016 48,000 48,000 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi VP-Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2016 65,000 65,000 - - Employee Stock Option (Right to Buy)
Habib Kairouz Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Mar 2016 247,727 3,068,057 - - Common Stock
Habib Kairouz Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Mar 2016 152,273 2,820,330 - - Common Stock
Martin A. Vogelbaum None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Mar 2016 247,727 3,068,057 - - Common Stock
Martin A. Vogelbaum None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Mar 2016 152,273 2,820,330 - - Common stock
Josef Schoell Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2016 8,000 0 - - Employee Stock Option (Right to Buy)
Josef Schoell Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2016 10,000 0 - - Employee Stock Option (Right to Buy)
Josef Schoell Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2016 8,000 36,000 - - Common Stock
Josef Schoell Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2016 10,000 46,000 - - Common Stock
Derek T. Chalmers Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2016 10,000 1,097,292 - - Common Stock
Derek T. Chalmers Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2016 10,000 30,000 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Feb 2016 1,000 129,000 - - Common Stock
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Feb 2016 5,000 130,000 - - Common Stock
Michael E. Lewis Chief Scientific Advisor Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Jan 2016 7,262 314,988 - - Common Stock
Derek T. Chalmers Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Jan 2016 12,500 1,087,292 - - Common Stock
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 Jan 2016 6,000 135,000 - - Common Stock
Dean Slagel None Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 Dec 2015 12,776 1,345,562 - - Common Stock
Dean Slagel None Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 Dec 2015 31,224 1,314,338 - - Common Stock
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Dec 2015 6,000 141,000 - - Common Stock
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Nov 2015 6,000 147,000 - - Common Stock
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Oct 2015 4,500 154,500 - - Common Stock
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Oct 2015 1,500 153,000 - - Common Stock
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Sep 2015 7,000 159,000 - - Common Stock
Josef Schoell Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 Aug 2015 3,000 28,000 - - Common Stock
Joseph Stauffer Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Aug 2015 2,000 13,442 - - Common Stock
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Aug 2015 7,000 166,000 - - Common Stock
Michael E. Lewis Chief Scientific Advisor Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jul 2015 7,262 322,250 - - Common Stock
Frederique Menzaghi VP-Research & Development Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jul 2015 7,000 173,000 - - Common Stock
Derek T. Chalmers Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 165,000 165,000 - - Employee Stock Option (Right to Buy)
Josef Schoell Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 30,000 30,000 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi VP-Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2015 60,000 60,000 - - Employee Stock Option (Right to Buy)
Harrison M. Bains None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2015 13,500 13,500 - - Stock Option (Right to Buy)
Martin A. Vogelbaum None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2015 13,500 13,500 - - Stock Option (Right to Buy)
Dean Slagel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2015 13,500 13,500 - - Stock Option (Right to Buy)
Jeffrey L. Ives None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2015 13,500 13,500 - - Stock Option (Right to Buy)
Michael E. Lewis Chief Scientific Advisor Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jun 2015 7,262 329,512 - - Common Stock
Dean Slagel None Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 May 2015 73,600 1,473,549 - - Common Stock
Dean Slagel None Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 May 2015 82,945 1,390,604 - - Common Stock
Dean Slagel None Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 May 2015 32,266 1,358,338 - - Common Stock
Michael E. Lewis Chief Scientific Advisor Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 May 2015 7,262 336,774 - - Common Stock
Michael E. Lewis Chief Scientific Advisor Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2015 7,262 344,036 - - Common Stock
Frederique Menzaghi VP-Research & Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2015 20,000 0 - - Employee Stock Option (Right to Buy)
Frederique Menzaghi VP-Research & Development Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2015 20,000 180,000 - - Common Stock
Michael E. Lewis Chief Scientific Advisor Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Mar 2015 7,262 351,298 - - Common Stock
Josef Schoell Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Feb 2015 15,000 25,000 - - Common Stock
Michael E. Lewis Chief Scientific Advisor Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Feb 2015 7,262 358,560 - - Common Stock
Joseph Stauffer Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2014 180,000 180,000 - - Employee Stock Option (Right to Buy)
Joseph Stauffer Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2014 11,442 11,442 - - Common Stock
Josef Schoell Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Aug 2014 40,000 0 - - Employee Stock Option (Right to Buy)
Josef Schoell Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Aug 2014 40,000 40,000 - - Common Stock
Harrison M. Bains None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jul 2014 20,000 20,000 - - Stock Option (Right to Buy)
Jeffrey L. Ives None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jul 2014 20,000 20,000 - - Stock Option (Right to Buy)
Robert Medve Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 120,000 120,000 - - Employee Stock Option (Right to Buy)
Farah Champsi Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Feb 2014 2,547 43,212 - - Common Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 531,442 1,650,117 - - Common Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 35,691 110,820 - - Common Stock
Farah Champsi Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Feb 2014 103,330 1,753,447 - - Common Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 1,118,675 1,118,675 - - Common Stock
Habib Kairouz Ten Percent Owner 05 Feb 2014 6,105,598 0 - - Series D Preferred Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 32,742 0 - - Series D Preferred Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 89,227 0 - - Series D Preferred Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 13,097 40,665 - - Common Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 27,568 27,568 - - Common Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 1,328,604 0 - - Series D Preferred Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 2,363,654 0 - - Series C Preferred Stock
Habib Kairouz Ten Percent Owner 05 Feb 2014 2,442,239 2,442,239 - - Common Stock
Farah Champsi Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Feb 2014 6,940 117,760 - - Common Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 58,250 0 - - Series C Preferred Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 75,129 75,129 - - Common Stock
Farah Champsi Ten Percent Owner 05 Feb 2014 158,741 0 - - Series C Preferred Stock
Habib Kairouz Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Feb 2014 225,818 2,668,057 - - Common Stock
Derek T. Chalmers Director, President & CEO 05 Feb 2014 200,000 0 - - Series A Preferred Stock
Derek T. Chalmers Director, President & CEO 05 Feb 2014 132,607 0 - - Series D Preferred Stock
Derek T. Chalmers Director, President & CEO 05 Feb 2014 80,000 1,046,750 - - Common Stock
Derek T. Chalmers Director, President & CEO 05 Feb 2014 53,042 1,099,792 - - Common Stock
Martin A. Vogelbaum None 05 Feb 2014 6,105,598 0 - - Series D Preferred Stock
Martin A. Vogelbaum None 05 Feb 2014 2,442,239 2,442,239 - - Common Stock
Martin A. Vogelbaum None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Feb 2014 225,818 2,668,057 - - Common Stock
Michael E. Lewis Chief Scientific Advisor 05 Feb 2014 100,000 0 - - Series A Preferred Stock
Michael E. Lewis Chief Scientific Advisor 05 Feb 2014 40,000 362,250 - - Common Stock
Michael E. Lewis Chief Scientific Advisor 05 Feb 2014 3,572 365,822 - - Common Stock
Michael E. Lewis Chief Scientific Advisor 05 Feb 2014 8,931 0 - - Series D Preferred Stock
Charles Moller None 05 Feb 2014 507,700 1,576,404 - - Common Stock
Charles Moller None 05 Feb 2014 2,258,065 0 - - Series C Preferred Stock
Charles Moller None 05 Feb 2014 1,269,254 0 - - Series D Preferred Stock
Charles Moller None 05 Feb 2014 1,068,704 1,068,704 - - Common Stock
Dean Slagel None 05 Feb 2014 84,149 1,547,149 - - Common Stock
Dean Slagel None 05 Feb 2014 80,000 1,463,000 - - Common Stock
Dean Slagel None 05 Feb 2014 200,000 0 - - Series A Preferred Stock
Dean Slagel None 05 Feb 2014 210,373 0 - - Series D Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters